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Abstract
Few studies have examined the efficacy of glucosamine, hyaluronic acid, 
and chondroitin sulfate supplements in horses.  The purpose of this study is 
to determine if the commercially available supplements are meeting the label 
guarantees, and to analyze any correlation between price point and efficacy 
of use. The supplemental ingredients of interest to this study are 
combinations of glucosamine, hyaluronic acid, and chondroitin sulfate. 
Horses in the study were fed each supplement for a 14-day period with 
synovial fluid extracted through aseptic arthrocentesis at days 0 and 14.  The 
12 horses followed a 14-day feeding period accompanied by a 28-day dry 
out period. This protocol was repeated 3 times, each with a different 
supplement. During these trials and the dry-out periods, the horses were 
divided into groups of 4 and exercised at different levels depending on the 
group. Physical data was collected on days 0 and 14 of each of the 3 trials to 
determine any physical differences associated with the use of the 
supplements. The veterinarian scored the horses at a walk and trot before 
carrying out flexion tests on all 4 limbs. The pulse, temperature, respiratory 
rate, and body condition scores were also collected. Enzyme-linked 
immunosorbent assays were used to quantify the amounts of chondroitin 
sulfate in each sample.  The results for the glucosamine and hyaluronic acid 
are still pending. 
Table 1: Pasture and Exercise Groupings
Objectives
The objectives of this research are to determine the efficacy of the 
supplements compared to the product recommendations and guarantees and 
to determine the correlation between price and the efficacy of the 
supplement.
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Introduction
Previous studies have evaluated lameness scores and sensitivity while feeding supplements to horses, but none have successfully evaluated the exact quantity of the molecules within the nutraceutical 
that reach the intended target. This study is focused on evaluating the exact quantity of chondroitin sulfate, hyaluronic acid, and glucosamine from the oral joint supplement reaching the joints in the 
horse. 
The evaluation of synovial fluid, blood serum, soundness evaluations, and flexion tests allows a quantification of the amount of each molecule reaching the joint as well as if the molecules are 
entering the cardiovascular system and whether the supplements are influencing any visual changes in the animal. 
Within this study, three different products were fed per product recommendations to twelve horses between the ages of seven and twenty-three. These products were evaluated to prove the efficacy of 
the supplement in reaching the target joint, the exact amount of each molecule were quantified through the specific assays for each molecule, and compared to the guarantees to determine the 
correlation between price and the efficacy of the specific supplement. Three other products were also be used to observe the amount of each molecule within the product compared to the label 
guarantee. 
Exercise regiments of different levels were tested to determine the connection between amounts of exercise and supplement efficacy. The samples of each supplement, blood serum, and synovial 
fluid were evaluated using enzyme-linked immunosorbent assays (ELISA) to quantify the chondroitin sulfate and hyaluronic acid. Fluorophore assisted carbohydrate electrophoresis (FACE) was 
used to quantify the glucosamine molecules in each supplement product. 
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Table 2: Supplement Differences
• 14 horses (13 Quarter Horses, 1 Arabian) were housed in open pastures 
in groups of 4 with individual feeding pens. 
• Horses were fed in individual pens and monitored to ensure 
consumption of the joint supplement. 
• The 12 horses within each trial followed a 14-day feeding period 
accompanied by a 28-day dry out period. This protocol was repeated 3 
times, each with a different supplement. 
• Synovial fluid was collected on days 0 and 14 and analyzed for 
Chondroitin Sulfate using ELISA (Antibody Research Corp.)
• The horses were divided into groups of 4 and exercised at different 
levels depending on the group.
• Physical data was collected on days 0 and 14 of each of the 3 trials. 
Physical data includes temperature, pulse, respiratory rate, body 
condition score, flexion tests, and soundness evaluations.
ID Gender Pasture Age Exercise
1 2 1 11 Moderate
2 1 1 7 Moderate
3 2 1 9 Moderate
4 2 1 9 Moderate
5 1 1 16 Moderate
6 1 2 10 Light
7 1 2 19 None
8 1 2 16 Light
9 1 2 22 None
10 1 3 19 Light
11 1 3 13 None
12 1 3 22 Light
13 1 3 22 Light
14 1 3 21 None
ID Supplement A Difference Supplement B Difference Supplement C Difference
1 4.574939 . .
2 . 2.3889 -0.492957746
3 7.308618 -11.8469 5.802816901
4 8.81139 40.90014 7.774647887
5 6.909927 34.14586 12.35211268
6 12.42844 6.845070423 4.716535
7 13.1524 -13.56338028 -8.656556
8 42.5598 -20.32394366 3.292183
9 16.5698 -1.830985915 3.6775
10 30.69014085 6.022616 -107.757074
11 53.98591549 10.024259 22.44357
12 . -7.472047 .
13 8.929577465 . 12.43536
14 43.422559 -2.238602 25.25899
Discussion
Joint disease is a significant concern among the performance horse industry due to the constant stress on their joints. Primary injuries may seem minor, but secondary injuries may present themselves 
later in life as joint disease caused by uneven weight bearing during the original injury.
Lameness evaluations were conducted on days 0 and 14 of each trial to determine any correlation between supplementation and physical changes. Graphs 2, 3, and 4 represent the data collected from 
the veterinarian over the 3 trials on the left front leg of each horse. The data showed no relationship between supplementation and physical change. 
Graphs 5, 6, and 7 represent each of the 3 fed supplements on day 0 and day 14. The graphs compare day 0 and day 14 to show the change in each horse’s synovial fluid chondroitin sulfate content. 
Supplement A presented a consistent increase from day 0 to day 14 in every horse without variation from environment or exercise regimen. Supplements B and C varied in the chondroitin sulfate data; 
the supplements showed an increase in some horses but a decrease in others. There are no patterns of consistency between pastures or exercise regimen.
The difference was taken between day 14 and day 0 for each supplement to represent a positive or negative change. Table 2 shows the differences of each horse for supplements A, B, and C. The 
results are represented in Graph 1 to show the drastic difference between the 3 supplements. According to the graph, supplement C showed the most negative differences, there were a few negative 
differences in supplement B, and only positive differences were found using supplement A. 
Along with the 3 supplements fed to the horses, another 3 supplements were added to the research in order to determine the quantity of molecules in each product. Since nutraceuticals are not 
regulated in North America, there is a difference in price and label guarantees from company to company. These 6 supplements were analyzed for hyaluronic acid and chondroitin sulfate content using 
ELISA kits and glucosamine using fluorophore-assisted carbohydrate electrophoresis. The results are shown in Table 3 representing the stated label guarantee and the analyzed quantity in the product. 
The hyaluronic acid assay only accurately quantified supplements A, C, and F, which all showed higher analyzed quantities than the label guarantees. The chondroitin sulfate assay showed half of the 
analyzed products had a lower chondroitin sulfate than stated on the label guarantee. The glucosamine assay found the label guarantees were much higher than the amount found during analysis for all 
supplement products. Table 3: Label Guarantee vs. Analyzed Quantity
Graph 5: Supplement A Comparison Graph 6: Supplement B Comparison 
-40
-20
0
20
40
60
80
100
120
140
160
1 3 4 5 6 7 8 9 10 11 13 14
Horse ID
Supplement A 
Day 0 vs. Day 14
Day 0
Day 14
Graph 7: Supplement C Comparison 
-20
0
20
40
60
80
100
120
140
2 3 4 5 6 7 8 9 10 11 12 14
Horse ID
Supplement B 
Day 0 vs. Day 14
Day 0
Day 14
-20
0
20
40
60
80
100
120
2 3 4 5 6 7 8 9 10 11 13 14
Horse ID
Supplement C 
Day 0 vs. Day 14
Day 0
Day 14
Product
HA Guarantee 
(mg/g)
HA Analysis 
(mg/g)
CS Guarantee 
(mg/g)
CS Analysis 
(mg/g)
Glucosamine 
Guarantee (mg/g)
Glucosamine 
Analysis (mg/g)
Supplement A 1.06 22.95 29.98 16.1985 88.18 7.74
Supplement B 2.94 . 70.59 47.5414 423.53 5.268
Supplement C 1.06 9.29 17.64 9.205 264.55 4.784
Supplement D 1.76 . 73.19 156.335 176.37 3.548
Supplement E 2 . 16 26.627 133.33 4.694
Supplement F 0.59 11.80 11.76 16.568 58.78 1.791
